loader
Home
Cheng Cameron Yin

EDITORIAL BOARD MEMBER - Cheng Cameron Yin


Cheng Cameron Yin

Anderson Cancer Center
USA

BIOGRAPHY:

Dr Cheng Cameron Yin is currently the Professor, The University of Texas Graduate School of Biomedical Sciences, Houston, TX. Dr. C. Cameron Yin has received her MD from Beijing Medical University and her PhD from the University of Wisconsin-Madison. She is board certified by the American Board of Pathology in Anatomic Pathology, Clinical Pathology, Hematology and Molecular Genetic Pathology. In addition to clinical responsibilities on the Leukemia, Lymphoma and Molecular Diagnostic Laboratory services, Dr. Yin has been actively participating in multiple research projects in leukemia and lymphoma, which has led to about 150 research papers and over 20 book chapters. She serves as members of editorial boards for over 20 journals and ad hoc reviewers for over 30 journals. Her major research interests include molecular genetic aberrations in leukemia and lymphoma, development of molecular methodologies for the diagnosis, prognosis and minimal residual disease monitoring of hematopoietic neoplasms, mechanisms of resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia, as well as the role of immunoglobulin gene rearrangement in acute myeloid leukemia.

RESEARCH INTERESTS:

Molecular genetic aberrations in leukemia and lymphoma Development of molecular methodologies for the diagnosis, prognosis and minimal residual disease monitoring of hematopoietic neoplasms Immunoglobulin gene rearrangement in acute myeloid leukemia